Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 64

1.

Factors Associated With Mental Health Status Among Older Primary Caregivers in Japan.

Ninomiya S, Tabuchi K, Rahman MM, Kobayashi T.

Inquiry. 2019 Jan-Dec;56:46958019859810. doi: 10.1177/0046958019859810.

2.

A comparative study of the physiological and psychological effects of forest bathing (Shinrin-yoku) on working age people with and without depressive tendencies.

Furuyashiki A, Tabuchi K, Norikoshi K, Kobayashi T, Oriyama S.

Environ Health Prev Med. 2019 Jun 22;24(1):46. doi: 10.1186/s12199-019-0800-1.

3.

Vestibular schwannoma extending into the tympanic cavity and jugular fossa by invasion of the petrous bone.

Matsumura H, Matsuda M, Tabuchi K, Yamamoto T, Ishikawa E, Matsumura A.

Br J Neurosurg. 2019 Mar 11:1-3. doi: 10.1080/02688697.2019.1588226. [Epub ahead of print]

PMID:
30856348
4.

Impact of Sphingolipid Mediators on the Determination of Cochlear Survival in Ototoxicity.

Tabuchi K, Hara A.

Curr Mol Pharmacol. 2018;11(4):279-284. doi: 10.2174/1874467211666180516101111. Review.

PMID:
29766830
5.

Modified combination of platelet count and neutrophil "to" lymphocyte ratio as a prognostic factor in patients with advanced head and neck cancer.

Nakayama M, Gosho M, Hirose Y, Nishimura B, Tanaka S, Tabuchi K, Okubo H, Wada T, Hara A.

Head Neck. 2018 Jun;40(6):1138-1146. doi: 10.1002/hed.25085. Epub 2018 Jan 31.

PMID:
29385295
6.

A qualitative study on the attributes of nurses' workplace social capital in Japan.

Norikoshi K, Kobayashi T, Tabuchi K.

J Nurs Manag. 2018 Jan;26(1):74-81. doi: 10.1111/jonm.12525. Epub 2017 Sep 25.

PMID:
28944981
7.

The role of peroxiredoxin I in cisplatin-induced ototoxicity.

Le Q, Tabuchi K, Warabi E, Hara A.

Auris Nasus Larynx. 2017 Apr;44(2):205-212. doi: 10.1016/j.anl.2016.06.001. Epub 2016 Jun 16.

PMID:
27318370
8.

Ceramide-1-phosphate protection of cochlear hair cells against cisplatin ototoxicity.

Le Q, Tabuchi K, Hara A.

Toxicol Rep. 2016 Apr 14;3:450-457. doi: 10.1016/j.toxrep.2016.04.003. eCollection 2016.

9.

Prognostic impact of salvage treatment on hearing recovery in patients with sudden sensorineural hearing loss refractory to systemic corticosteroids: A retrospective observational study.

Nakagawa T, Yamamoto M, Kumakawa K, Usami S, Hato N, Tabuchi K, Takahashi M, Fujiwara K, Sasaki A, Komune S, Yamamoto N, Hiraumi H, Sakamoto T, Shimizu A, Ito J.

Auris Nasus Larynx. 2016 Oct;43(5):489-94. doi: 10.1016/j.anl.2015.12.004. Epub 2015 Dec 29.

PMID:
26739948
10.

Hair Cell Loss Induced by Sphingosine and a Sphingosine Kinase Inhibitor in the Rat Cochlea.

Tani K, Tabuchi K, Hara A.

Neurotox Res. 2016 Jan;29(1):35-46.

PMID:
26472207
11.

Evaluation of percutaneous transluminal angioplasty screening using color Doppler ultrasonography.

Tabuchi K, Kobayashi T, Kumagai J, Takahashi N.

J Vasc Access. 2015 Nov;16 Suppl 10:S53-7. doi: 10.5301/jva.5000448. Epub 2015 Aug 27.

PMID:
26349874
12.

A randomized controlled clinical trial of topical insulin-like growth factor-1 therapy for sudden deafness refractory to systemic corticosteroid treatment.

Nakagawa T, Kumakawa K, Usami S, Hato N, Tabuchi K, Takahashi M, Fujiwara K, Sasaki A, Komune S, Sakamoto T, Hiraumi H, Yamamoto N, Tanaka S, Tada H, Yamamoto M, Yonezawa A, Ito-Ihara T, Ikeda T, Shimizu A, Tabata Y, Ito J.

BMC Med. 2014 Nov 19;12:219. doi: 10.1186/s12916-014-0219-x.

13.

Clinical utility of the modified Glasgow prognostic score in patients with advanced head and neck cancer.

Nakayama M, Tabuchi K, Hara A.

Head Neck. 2015 Dec;37(12):1745-9. doi: 10.1002/hed.23823. Epub 2014 Sep 25.

PMID:
24989115
14.

Ceramide/sphingomyelin cycle involvement in gentamicin-induced cochlear hair cell death.

Chi le NU, Tabuchi K, Nakamagoe M, Nakayama M, Nishimura B, Hara A.

Arch Toxicol. 2015 Mar;89(3):415-21. doi: 10.1007/s00204-014-1259-x. Epub 2014 May 6.

PMID:
24798086
15.

[Immunoelectron microscopic analysis of neurotoxic effect of glutamate in the vestibular end organs during ischemia].

Sasaki A, Matsubara A, Tabuchi K, Hara A, Namba A, Yamamoto Y, Shinkawa H.

Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2014 Jan;28(2):122-6. Chinese. No abstract available.

PMID:
24738318
16.

The influence of sphingosine-1-phosphate receptor antagonists on gentamicin-induced hair cell loss of the rat cochlea.

Nakayama M, Tabuchi K, Hoshino T, Nakamagoe M, Nishimura B, Hara A.

Neurosci Lett. 2014 Feb 21;561:91-5. doi: 10.1016/j.neulet.2013.12.063. Epub 2014 Jan 5.

PMID:
24397911
17.

Combined transmastoid/middle fossa approach for intracranial extension of middle ear cholesteatoma.

Tabuchi K, Yamamoto T, Akutsu H, Suzuki K, Hara A.

Neurol Med Chir (Tokyo). 2012;52(10):736-40.

18.

The effects of A1 and A2A adenosine receptor agonists on kainic acid excitotoxicity in the guinea pig cochlea.

Tabuchi K, Sakai S, Nakayama M, Nishimura B, Hayashi K, Hirose Y, Hara A.

Neurosci Lett. 2012 Jun 14;518(1):60-3. doi: 10.1016/j.neulet.2012.04.057. Epub 2012 May 3.

PMID:
22580201
19.

Immunoelectron microscopic analysis of neurotoxic effect of glutamate in the vestibular end organs during ischemia.

Sasaki A, Matsubara A, Tabuchi K, Hara A, Namba A, Yamamoto Y, Shinkawa H.

Acta Otolaryngol. 2012 Jul;132(7):686-92. doi: 10.3109/00016489.2012.656322. Epub 2012 Apr 12.

PMID:
22497451
20.

Outcome of T4 (International Union Against Cancer Staging System, 7th edition) or recurrent nasal cavity and paranasal sinus carcinoma treated with proton beam.

Fukumitsu N, Okumura T, Mizumoto M, Oshiro Y, Hashimoto T, Kanemoto A, Hashii H, Ohkawa A, Moritake T, Tsuboi K, Tabuchi K, Wada T, Hara A, Sakurai H.

Int J Radiat Oncol Biol Phys. 2012 Jun 1;83(2):704-11. doi: 10.1016/j.ijrobp.2011.07.032. Epub 2011 Nov 16.

PMID:
22099036

Supplemental Content

Loading ...
Support Center